Citation Impact
Citing Papers
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients
1998
Use of itraconazole in a patient with chronic mucocutaneous candidiasis
1989
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
“On Water”: Unique Reactivity of Organic Compounds in Aqueous Suspension
2005 StandoutNobel
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole
1994
Detection of Galactomannan and the 18 kDa Antigen from Aspergillus fumigatus in Serum and Urine from Cattle with Systemic Aspergillosis
1993
Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients
1994
Itraconazole
1989
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines
2007 StandoutNatureNobel
Modular click chemistry libraries for functional screens using a diazotizing reagent
2019 StandoutNatureNobel
The capsaicin receptor: a heat-activated ion channel in the pain pathway
1997 StandoutNatureNobel
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Mechanically bonded macromolecules
2009 StandoutNobel
Biocompatible Carbon Nanotubes Generated by Functionalization with Glycodendrimers
2008 StandoutNobel
Anti-CandidaDrugs — The Biochemical Basis for Their Activity
1987
Vitamin D Deficiency
2007 Standout
Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients
1994
Fluconazole
1990
Aspergillus Antigen Detection in the Diagnosis of Invasive Aspergillosis
1995
Treatment of invasive aspergillosis with itraconazole
1989
Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation
1998
A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes
2002 StandoutNobel
Click Chemistry: Diverse Chemical Function from a Few Good Reactions
2001 StandoutNobel
Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection
1994
Drug resistance in human pathogenic fungi
1992
Itraconazole: pharmacology, clinical experience and future development
1996
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Detection of (1–3)‐β‐D ‐glucan in a rat model of aspergillosis
1995
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
Efficiency and Fidelity in a Click‐Chemistry Route to Triazole Dendrimers by the Copper(I )‐Catalyzed Ligation of Azides and Alkynes
2004 StandoutNobel
Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole
1991
Highly sensitive detection of fungal antigens by ultrasound-enhanced latex agglutination
1995
Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics
2001
Oral therapeutic agents in fungal nail disease
1994
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents
1992
In vitro and in vivo evaluation of antifungal agents
1989
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen
1994
Click Chemistry In Situ: Acetylcholinesterase as a Reaction Vessel for the Selective Assembly of a Femtomolar Inhibitor from an Array of Building Blocks
2002 StandoutNobel
Detection of galactomannan and complement activation in the pregnant mouse during experimental systemic aspergillosis
1996
SuFEx‐Based Synthesis of Polysulfates
2014 StandoutNobel
Organic Switches for Surfaces and Devices
2012 StandoutNobel
Reactivity of Biarylazacyclooctynones in Copper-Free Click Chemistry
2012 StandoutNobel
New approaches to the treatment of onychomycosis
1993
Oxime-assisted Acetylcholinesterase Catalytic Scavengers of Organophosphates That Resist Aging
2011 StandoutNobel
Diagnosis of systemic mycoses by specific immunohistochemical tests
1996
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation
1991
Prevention of Invasive Fungal Infections in Patients with Neoplastic Diseases
1993
Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies
1994
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B
1991
SuFEx‐Based Polysulfonate Formation from Ethenesulfonyl Fluoride–Amine Adducts
2017 StandoutNobel
Copper(I)-Catalyzed Synthesis of Azoles. DFT Study Predicts Unprecedented Reactivity and Intermediates
2004 StandoutNobel
Adjustable Receptor Based on a [3]Rotaxane Whose Two Threaded Rings Are Rigidly Attached to Two Porphyrinic Plates: Synthesis and Complexation Studies
2009 StandoutNobel
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigatus and several other species of Aspergillus
1992
Antifungal agents: chemotherapeutic targets and immunologic strategies
1996
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Pillar[5]arene as a Co-Factor in Templating Rotaxane Formation
2013 StandoutNobel
Multidimensional SuFEx Click Chemistry: Sequential Sulfur(VI) Fluoride Exchange Connections of Diverse Modules Launched From An SOF4 Hub
2017 StandoutNobel
Zygomycetes in Human Disease
2000 Standout
Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis
1995
Virulence factors of medically important fungi
1996
Characterization of an azole-resistant Candida glabrata isolate
1992
Cooperative capture synthesis: yet another playground for copper-free click chemistry
2016 StandoutNobel
Pharmacokinetics of itraconazole following oral administration to normal volunteers
1988
Rat monoclonal antibodies against Aspergillus galactomannan
1992
Development of a Bioorthogonal and Highly Efficient Conjugation Method for Quantum Dots Using Tetrazine−Norbornene Cycloaddition
2010 StandoutNobel
A Liquid‐Crystalline Bistable [2]Rotaxane
2007 StandoutNobel
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole
1993
Cooperative Reactivity in an Extended-Viologen-Based Cyclophane
2016 StandoutNobel
Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels
1989
Serodiagnosis of Aspergillosis
1991
Amphotericin B lipid complex therapy of experimental fungal infections in mice
1991
Biocompatible SuFEx Click Chemistry: Thionyl Tetrafluoride (SOF4)‐Derived Connective Hubs for Bioconjugation to DNA and Proteins
2019 StandoutNobel
Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations
1993
Dual-Controlled Nanoparticles Exhibiting AND Logic
2009 StandoutNobel
Click-Chemie: diverse chemische Funktionalität mit einer Handvoll guter Reaktionen
2001 StandoutNobel
Early Experience with Itraconazole in Vitro and in Patients: Pharmacokinetic Studies and Clinical Results
1987
Click Chemistry: Diverse Chemical Function from a Few Good Reactions
2001 StandoutNobel
Monofunctionalized Gold Nanoparticles Stabilized by a Single Dendrimer Form Dumbbell Structures upon Homocoupling
2012 StandoutNobel
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence
1997
Mechanism and Scope of Base‐Controlled Catalyst‐Free N‐Arylation of Amines with Unactivated Fluorobenzenes
2016 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
Experimental models in antifungal chemotherapy
1998
Antigenicity ofAspergillusspecies
1992
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
Resistance of Candida species to fluconazole
1995
Aspergillus infection: does serodiagnosis work?
1993
SK&F 96365, a novel inhibitor of receptor-mediated calcium entry
1990
Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis
1993
Acid−Base Actuation of [c2]Daisy Chains
2009 StandoutNobel
Guidelines for Treatment of Candidiasis
2004 Standout
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units
1997
Mechanical Bond-Induced Radical Stabilization
2012 StandoutNobel
Bone metabolism and disease in chronic kidney disease
2003
Second-Generation Difluorinated Cyclooctynes for Copper-Free Click Chemistry
2008 StandoutNobel
Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry
2020 StandoutNobel
Immunodiagnosis of aspergillosis
1991
Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models
1998
A New Portal to SuFEx Click Chemistry: A Stable Fluorosulfuryl Imidazolium Salt Emerging as an “F−SO2+” Donor of Unprecedented Reactivity, Selectivity, and Scope
2017 StandoutNobel
Repeated-Dose Pharmacokinetics of an Oral Solution of Itraconazole in Infants and Children
1998
Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients
1994
Works of J. Van Cutsem being referenced
The Activity of Ketoconazole and Itraconazole Against Aspergillus fumigatus in Mixed Cultures with Macrophages or Leukocytes/Die Aktivität von Ketoconazol und Itraconazol gegen Aspergillus fumigatus in Mischkulturen mit Makrophagen oder Leukozyten
1986
Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)
1989
Phase II trial: An evaluation of oral saperconazole in acute vaginal candidosis: a comparison of three dosage schedules
1991
Treatment of Experimental Zygomycosis in Guinea Pigs with Azoles and with Amphotericin B
1989
Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts
1992
Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect
1994
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.
1993
Posttreatment itraconazole levels in the nail
1992
Detection of Circulating Galactomannan by Pastorex Aspergillus in Experimental Invasive Aspergillosis
1990
Experimental aspergillosis in guinea pigs: influence of itraconazole on fungaemia and invasive fungal growth
1994
In vitro Antifungal Spectrum of Itraconazole and Treatment of Systemic Mycoses with Old and New Antimycotic Agents
1992
IMMUNOHISTOCHEMICAL IDENTIFICATION OF PENICILLIUM MARNEFFEI BY MONOCLONAL ANTIBODY
1992
Monoclonal antibody‐gold silver staining dot assay for the detection of antigenaemia in candidosis
1991
Experimental Systemic Dermatophytosis
1984
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones
1984
The influence of gastric acidity on the bio-availability of ketoconazole
1980
Culture Media for the Study of the Effects of Azole Derivatives on Germ Tube Formation and Hyphal Growth of C. albicans/Nährböden zur Untersuchung der Wirkungen von Azolderivaten auf die Keimschlauchbildung und das Hyphenwachstum bei C. albicans
1986
Azole resistance inCandida albicans
1986
Activity of Orally, Topically, and Parenterally Administered Itraconazole in the Treatment of Superficial and Deep Mycoses: Animal Models
1987
The In‐vitro Antifungal Spectrum of Itraconazole
1989
Azole resistance in Candida albicans.
1986
The in-vitro antifungal spectrum of itraconazole.
1989
SAPERCONAZOLE, A NEW POTENT ANTIFUNGAL TRIAZOLE: IN VITRO ACTIVITY SPECTRUM AND THERAPEUTIC EFFICACY
1989
Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
1990
Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals
1989
Preparation and antimycotic properties of derivatives of 1-phenethylimidazole
1969
Treatment of Gastrointestinal Candidosis in Predisposed Guinea-Pigs and in Conventional Mice with Miconazole
1978
Therapeutic Efficacy of Itraconazole in Systemic Candidosis in Guinea Pigs
1987
Oral, Topical and Parenteral Antifungal Treatment with Itraconazole in Normal and in Immunocompromised Animals
1989
Effect of tissue invasion and treatment with itraconazole or amphotericin B on galactomannan levels in plasma of guinea-pigs with experimental invasive aspergillosis
1993
Observations on candidal vaginitis
1972
Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermotropism in guinea-pigs.
1986
Itraconazole, a new triazole that is orally active in aspergillosis
1984
Experimental Zygomycosis Due toRhizopusspp. Infection by Various Routes in Guinea‐Pigs, Rats and Mice
1988
The in vivo antifungal activity of broad‐spectrum azoles
1986
Experimental cutaneousCandida albicansinfection in guinea-pigs
1971
Antimycotic imidazoles. Part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent
1979
The antifungal activity of ketoconazole
1983
Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology
1985
The Clinical Pharmacokinetics of Itraconazole: An Overview
1989